Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer

International Journal of Radiation Oncology Biology Physics

Volumn 61, Issue 4, 2005, Pages 1087-1095

  Prosnitz, Robert G ^a   Yao, Bin ^b   Farrell, Catherine L ^b   Clough, Robert ^a   Brizel, David M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b AMGEN INC   (United States)

Author keywords

Anemia; Combined modality therapy; Head and neck cancer; Hyperfractionation; Radiotherapy

Indexed keywords

CELLS; CHEMOTHERAPY; DISEASES; HEMOGLOBIN; PATIENT TREATMENT; TUMORS;

ANEMIA CORRECTION; CONCURRENT CHEMOTHERAPY (CCT); HEAD-AND-NECK CANCER (HNC); HYPERFRACTIONATED IRRADIATION;

RADIOTHERAPY;

CISPLATIN; FLUOROURACIL; HEMOGLOBIN;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HEAD CANCER; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; NASOPHARYNX CANCER; NECK CANCER; OROPHARYNX CANCER; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; ANALYSIS OF VARIANCE; ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; TREATMENT FAILURE;

EID: 14844292125     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.07.710     Document Type: Article

References (31)

1. J.T. Fazekas, C. Scott, V. Marcial The role of hemoglobin concentration in the outcome of misonidazole-sensitized radiotherapy of head and neck cancers: Based on RTOG trial #79-15 Int J Radiat Oncol Biol Phys 17 1989 1177 1181
2. D.M. Brizel, M.E. Albers, S.R. Fisher Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer N Engl J Med 338 1998 1798 1804
3. D.A. Fein, W.R. Lee, A.L. Hanlon Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx J Clin Oncol 13 1995 2077 2083
4. R. Tarnawski, K. Skladowski, B. Maciejewski Prognostic value of hemoglobin concentration in radiotherapy for cancer of supraglottic larynx Int J Radiat Oncol Biol Phys 38 1997 1007 1011
5. M.J. van Acht, J. Hermans, D.E. Boks The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma Radiother Oncol 23 1992 229 235
6. P. Warde, B. O'Sullivan, R.G. Bristow T1/T2 glottic cancer managed by external beam radiotherapy: The influence of pretreatment hemoglobin on local control Int J Radiat Oncol Biol Phys 41 1998 347 353
7. G. Calais, M. Alfonsi, E. Bardet Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma J Natl Cancer Inst 91 1999 2081 2086
8. M. Merlano, M. Benasso, R. Corvo Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck J Natl Cancer Inst 88 1996 583 589
9. T.G. Wendt, G.G. Grabenbauer, C.M. Rodel Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study J Clin Oncol 16 1998 1318 1324
10. M. Al-Sarraf, M. LeBlanc, P.G. Giri Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099 J Clin Oncol 16 1998 1310 1317
11. D.J. Adelstein, G.L. Adams, Y. Li A phase III comparison of standard radiation therapy (RT) versus RT plus concurrent cisplatin (DDP) versus split-course RT plus concurrent DDP and 5-fluorouracil (5FU) in patients with unresectable squamous cell head and neck cancer (SCHNC): An Intergroup study Proc Am Soc Clin Oncol 19 2000 411a
12. D.M. Brizel, R.K. Dodge, R.W. Clough Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome Radiother Oncol 53 1999 113 117
13. P.H. Blitzer, C.C. Wang, H.D. Suit Blood pressure and hemoglobin concentration: Multivariate analysis of local control after irradiation for head and neck cancer Int J Radiat Oncol Biol Phys 10 Suppl. 2 1984 98
14. W.R. Lee, B. Berkey, V. Marcial Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: A secondary analysis of RTOG 85-27 Int J Radiat Oncol Biol Phys 42 1998 1069 1075
15. G. Lammering, U.M. Carl, H. Pape Anderungen der Hamoglobinkonzentration bei kombinierter Radio- und Chemotherapie lokal fortgeschrittener HNO-Tumoren Strahlentherapie und Onkologie 175 1999 559 562
16. F. Denis, P. Garaud, E. Bardet Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma J Clin Oncol 22 2004 69 76
17. C.M. Glaser, W. Millesi, G.V. Kornek Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx Int J Radiat Oncol Biol Phys 50 2001 705 715
18. P. Stadler, A. Becker, H.J. Feldmann Influence of the hypoxic subvolume on the survival of patients with head and neck cancer Int J Radiat Oncol Biol Phys 44 1999 749 754
19. J. Dunst, P. Stadler, A. Becker Tumor volume and tumor hypoxia in head and neck cancers: The amount of the hypoxic volume is important Strahlentherapie und Onkologie 179 2003 521 526
20. A. Becker, P. Stadler, R.S. Lavey Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas Int J Radiat Oncol Biol Phys 46 2000 459 466
21. R.S. Bush Current status and treatment of localized disease and future aspects Int J Radiat Oncol Biol Phys 10 1984 1165 1174
22. A.W. Fyles, M. Milosevic, M. Pintilie Anemia, hypoxia and transfusion in patients with cervix cancer: A review Radiother Oncol 57 2000 13 19
23. M. Benasso, R. Corvo, R. Rosso Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study J Natl Cancer Inst 88 1996 583 589
24. J.L. Gabrilove, C.S. Cleeland, R.B. Livingston Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing J Clin Oncol 19 2001 2875 2882
25. Littlewood TJ, Nortier J, Rapoport B et al. Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy. Hematol Oncol 2003;21:169-180.
26. A. Osterborg, Y. Brandberg, V. Molostova Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin beta, in hematologic malignancies J Clin Oncol 20 2002 2486 2494
27. J. Overgaard, H.S. Hansen, K. Jorgensen Primary radiotherapy of larynx and pharynx carcinoma--an analysis of some factors influencing local control and survival Int J Radiat Oncol Biol Phys 12 1986 515 521
28. F.R. Rosen, D. Haraf, B. Brockstein Multicenter randomized phase II study of 1 hour (H) infusion paclitaxel (T), flourouracil (F) and hydroxyruea (H) with concomitant hyperfractionated radiotherapy (2XRT) with or without erythropoietin (EPO) for advanced head and neck cancer (HNC) J Clin Oncol 20 2001 226a
29. M. Henke, R. Laszig, C. Rube Erythoropoeitin to treat head and neck cancer patients with anaemia undergoing radiotherapy: Randomized, double-blind, placebo-controlled trial Lancet 362 2003 1255 1260
30. C.J. Gulledge, M.W. Dewhirst Tumor oxygenation: A matter of supply and demand Anticancer Res 16 1996 741 749
31. H.R. Withers, J.M. Taylor, B. Maciejewski The hazard of accelerated tumor clonogen repopulation during radiotherapy Acta Oncologica 27 1988 131 146